|
 Anat Eitan, the founder and CEO of VacciGuard has more than twenty years of experience in various positions, including senior managerial functions in the drug development industry.
She worked in the Innovative R&D division at Teva Pharmaceutical Industries for 12 years, starting as a project manager and later re-established and headed the new projects unit of the firm.
She was the CEO of Metabogal (now Protalix) and a partner in the Pontifax Investment Fund.
She brings experience in consulting to investment firms, technology transfer organizations and biotechnology companies.
|
